This page shows Cartesian Growth Corp Iii (CGCT) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Cartesian Growth Corp Iii's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Cartesian Growth Corp Iii's current ratio of 0.89 is below the typical benchmark, resulting in a score of 12/100. However, the company holds substantial cash reserves (75% of current liabilities), which buffers actual liquidity risk. Large mature operators often run tight current ratios by design.
For every $1 of reported earnings, Cartesian Growth Corp Iii generates $-0.08 in operating cash flow (-$504K OCF vs $6.2M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
Cartesian Growth Corp Iii reported $6.2M in net income in fiscal year 2025.
Cartesian Growth Corp Iii earned $0.25 per diluted share (EPS) in fiscal year 2025.
Cash & Balance Sheet
Cartesian Growth Corp Iii held $624K in cash against $0 in long-term debt as of fiscal year 2025.
Cartesian Growth Corp Iii had 28M shares outstanding in fiscal year 2025.
Margins & Returns
Capital Allocation
CGCT Income Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 |
|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A |
| SG&A Expenses | $137K-69.4% | $449K+2093.6% | $20K | N/A |
| Operating Income | -$137K+69.4% | -$449K | N/A | N/A |
| Interest Expense | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | $0 | $0 |
| Net Income | $2.8M+109.6% | $1.3M+6551.0% | -$20K | N/A |
| EPS (Diluted) | N/A | N/A | N/A | N/A |
CGCT Balance Sheet
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 |
|---|---|---|---|---|
| Total Assets | $281.6M+1.0% | $278.8M+39396.5% | $706K+164.5% | $267K |
| Current Assets | $825K-14.0% | $960K | N/A | $3K |
| Cash & Equivalents | $0 | $0 | $0 | $0 |
| Inventory | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A |
| Total Liabilities | $294.2M+1.0% | $291.3M+39056.7% | $744K+161.5% | $284K |
| Current Liabilities | $396K-6.1% | $422K-43.3% | $744K+161.5% | $284K |
| Long-Term Debt | N/A | N/A | N/A | N/A |
| Total Equity | -$12.6M-1.1% | -$12.5M-32756.4% | -$38K-116.1% | -$18K |
| Retained Earnings | -$12.6M-1.1% | -$12.5M-19733.5% | -$63K-48.0% | -$43K |
CGCT Cash Flow Statement
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 |
|---|---|---|---|---|
| Operating Cash Flow | -$167K | N/A | N/A | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $0 | N/A | N/A | N/A |
| Financing Cash Flow | $0 | N/A | N/A | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A |
CGCT Financial Ratios
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 |
|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A |
| Return on Assets | 1.0%+0.5pp | 0.5%+3.4pp | -2.9% | N/A |
| Current Ratio | 2.08-0.2 | 2.28 | N/A | 0.01 |
| Debt-to-Equity | -23.27+0.0 | -23.29-3.7 | -19.54-3.4 | -16.15 |
| FCF Margin | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$13.2M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.89), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Frequently Asked Questions
Is Cartesian Growth Corp Iii profitable?
Yes, Cartesian Growth Corp Iii (CGCT) reported a net income of $6.2M in fiscal year 2025.
What is Cartesian Growth Corp Iii's operating cash flow?
Cartesian Growth Corp Iii (CGCT) generated -$504K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Cartesian Growth Corp Iii's total assets?
Cartesian Growth Corp Iii (CGCT) had $284.2M in total assets as of fiscal year 2025, including both current and long-term assets.
What is Cartesian Growth Corp Iii's current ratio?
Cartesian Growth Corp Iii (CGCT) had a current ratio of 0.89 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Cartesian Growth Corp Iii's debt-to-equity ratio?
Cartesian Growth Corp Iii (CGCT) had a debt-to-equity ratio of -22.53 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Cartesian Growth Corp Iii's return on assets (ROA)?
Cartesian Growth Corp Iii (CGCT) had a return on assets of 2.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Cartesian Growth Corp Iii's cash runway?
Based on fiscal year 2025 data, Cartesian Growth Corp Iii (CGCT) had $624K in cash against an annual operating cash burn of $504K. This gives an estimated cash runway of approximately 15 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Cartesian Growth Corp Iii's debt-to-equity ratio negative or unusual?
Cartesian Growth Corp Iii (CGCT) has negative shareholder equity of -$13.2M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
Are Cartesian Growth Corp Iii's earnings high quality?
Cartesian Growth Corp Iii (CGCT) has an earnings quality ratio of -0.08x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Cartesian Growth Corp Iii?
Cartesian Growth Corp Iii (CGCT) scores 2 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.